[Diabetes and pancreatic cancer - When diabetes indicates a pancreatic cancer].

Autor:	Moulin K; Service de médecine interne générale, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14., Gastaldi G; Service d'endocrinologie, diabétologie, nutrition et éducation thérapeutique du patient, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14., Serratrice J; Service de médecine interne générale, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14., Baroz F; Service de médecine interne générale, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.
Jazyk:	francouzština
Zdroj:	Revue medicale suisse [Rev Med Suisse] 2022 Oct 26; Vol. 18 (801), pp. 1994-1998.
DOI:	10.53738/REVMED.2022.18.801.1994
Abstrakt:	Diabetes and pancreatic cancer have an intricate relationship where each is a risk factor for developing the other. In case of type 2 diabetes, there is an increased probability of developing pancreatic cancer. Similarly, the onset of diabetes often precedes the diagnosis of pancreatic cancer. Since hyperglycemia is secondary to tumor involvement of the exocrine pancreas, diabetes is considered pancreatogenic. In the current classification, it is part of the entities belonging to type 3c diabetes. The pathophysiology is specific, characterized by a high glycemic variability and a tendency to weight loss. Early identification of inaugural type 3c diabetes would reduce diagnostic delays and could optimize oncologic management. In the absence of specific markers, the challenge for the clinician is indisputable. Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu